|
|
|
40
|
B4911
|
XOLAIR 150MG INJ (NVS/COL) OMALIZUMAB
|
OMALIZUMAB
|
XOLAIR
|
150MG VIAL
|
C
|
1,304.93
|
1,304.93
|
INJECTION
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
B4911
|
XOLAIR 150MG INJ (NVS) OMALIZUMAB (C)
|
OMALIZUMAB
|
XOLAIR
|
150MG VIAL
|
C
|
1304.93
|
1304.9314
|
VIAL
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
RESPIRATORY INFLAMMATORY AGENTS
|
|
|
|
|
42
|
B4911
|
XOLAIR 150MG INJ (NVS) OMALIZUMAB
|
OMALIZUMAB
|
XOLAIR
|
150MG VIAL
|
C
|
1,304.93
|
1,304.93
|
VIAL
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
RESPIRATORY INFLAMMATORY AGENTS
|
|
|
|
|
40
|
B4913
|
OMALIREL 150MG INJ (RLS/AHI) OMALIZUMAB
|
OMALIZUMAB
|
OMALIREL
|
150MG VIAL
|
C
|
844.86
|
844.86
|
INJECTION
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
B4913
|
OMALIREL 150MG INJ (RLS) OMALIZUMAB (C)
|
OMALIZUMAB
|
OMALIREL
|
150MG VIAL
|
C
|
844.86
|
844.8551
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
RESPIRATORY INFLAMMATORY AGENTS
|
|
|
|
|
42
|
B4913
|
OMALIREL 150MG INJ (RLS) OMALIZUMAB
|
OMALIZUMAB
|
OMALIREL
|
150MG VIAL
|
BQ
|
747.54
|
747.54
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
RESPIRATORY INFLAMMATORY AGENTS
|
|